This Article Full Text Full Text (PDF) All Versions of this Article: 40/3/942    most recent STROKEAHA.108.532556v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aoki, T. Articles by Hashimoto, N. Search for Related Content PubMed PubMed Citation Articles by Aoki, T. Articles by Hashimoto, N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Brain Aneurysm Related Collections Animal models of human disease Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Aneurysm, AVM, hematoma Other Vascular biology

(Stroke. 2009;40:942.)
© 2009 American Heart Association, Inc.

Original Contributions

Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation

Tomohiro Aoki, MD; Hiroharu Kataoka, MD, PhD; Ryota Ishibashi, MD; Kazuhiko Nozaki, MD, PhD; Kensuke Egashira, MD, PhD Nobuo Hashimoto, MD, PhD

From the Department of Neurosurgery (T.A., H.K., R.I., K.N., N.H.), Kyoto University Graduate School of Medicine, Kyoto, Japan; and the Department of Cardiovascular Medicine (K.E.), Kyushu University Graduate School of Medical Science, Fukuoka, Japan.

Correspondence to Hiroharu Kataoka, MD, PhD, Department of Neurosurgery, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. E-mail kataoka{at}kuhp.kyoto-u.ac.jp

Background and Purpose— Recent studies have suggested that chronic inflammation actively participates in cerebral aneurysm (CA) formation. Macrophages accumulate in CA walls and express proinflammatory genes promoting CA progression, but the molecular mechanisms of monocyte/macrophage recruitment into CA walls remain to be elucidated.

Methods— Monocyte chemoattractant protein-1 (MCP-1) expression in experimentally induced CAs was assessed by immunohistochemistry and Western blotting. The role of MCP-1 in CA formation was examined by MCP-1^–/– mice and a plasmid DNA encoding a dominant negative mutant of MCP-1 (7ND). MCP-1 expression in human CAs was examined by immunohistochemistry.

Results— MCP-1 expression was upregulated in aneurysmal walls at the early stage of CA formation. MCP-1^–/– mice exhibited a significant decrease of CA formation and macrophage accumulation with decreased expression of matrix metalloproteinase-2, -9, and inducible nitric oxide synthase. Immunohistochemistry for the DNA binding form of nuclear factor-kappa B showed nuclear factor-kappa B activation in MCP-1-expressing cells. Blockade of MCP-1 activity by 7ND resulted in the inhibition of CA progression in rats. In human CAs, MCP-1 was also expressed in CA walls.

Conclusions— These data suggest that MCP-1 plays a crucial role in CA formation as a major chemoattractant for monocyte/macrophage. MCP-1 expression in CA walls is induced through nuclear factor-kappa B activation. MCP-1 may be a novel therapeutic target of medical treatment preventing CA progression.

Key Words: animal model • CCL-2 • cerebral aneurysm • macrophage • MCP-1

This article has been cited by other articles:

				Y. Tada, K. T. Kitazato, T. Tamura, K. Yagi, K. Shimada, T. Kinouchi, J. Satomi, and S. Nagahiro Role of Mineralocorticoid Receptor on Experimental Cerebral Aneurysms in Rats Hypertension, September 1, 2009; 54(3): 552 - 557. [Abstract] [Full Text] [PDF]

				T. Aoki, H. Kataoka, R. Ishibashi, K. Nozaki, R. Morishita, and N. Hashimoto Reduced Collagen Biosynthesis Is the Hallmark of Cerebral Aneurysm: Contribution of Interleukin-1{beta} and Nuclear Factor-{kappa}B Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1080 - 1086. [Abstract] [Full Text] [PDF]